Search - tctmd.com

Displaying 61 - 80 of 1558

Sort: Relevancy | Date

Presentation TCT 2025

Commentary

Presenter: Stefan Blankenberg

October 27, 2025

Presentation TCT 2025

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Presenter: Donald Cutlip

October 27, 2025

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation TCT 2025

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Presenter: Roseann M. White

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Bernard Prendergast

October 27, 2025

Presentation TCT 2025

How to Design (and How Not to Design) a Non-Inferiority Trial

Presenter: Kevin Bainey

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

Presentation TCT 2025

Real-World Data from Data Aggregators: Opportunities and Challenges

Presenter: Ryan Ahern

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Presenter: Robert W. Yeh

October 27, 2025

Presentation TCT 2025

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Presenter: Mitchell W. Krucoff

October 27, 2025

Presentation TCT 2025

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

Presenter: Ben Saville

October 27, 2025

Presentation TCT 2025

Mapping the Evidence: A Review of the Renal Denervation Clinical Trial Landscape

Presenter: Eric A. Secemsky

October 26, 2025

Presentation TCT 2025

The Conformal LAAC Device: Status Update and Current IDE Clinical Trial

Presenter: William A. Gray

October 26, 2025

Presentation TCT 2025

TCT 649: Five-Year Clinical Outcomes of the Randomized Controlled Trial of Angiography Versus Pressure Ratio-Guided Enhancement Techniques - Fractional Flow Reserve (TARGET-FFR)

Presenter: Damien Collison

October 26, 2025

Presentation TCT 2025

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Presenter: Jonathan G. Schwartz

October 26, 2025

Presentation TCT 2025

TCT 982: Clinical Characteristics and Outcomes of Transcatheter Tricuspid Valve Replacement (TTVR) Patients Stratified by TRISCEND II Trial Eligibility

Presenter: Sureja Sundaralingam

October 26, 2025

Presentation TCT 2025

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Presenter: Raj Makkar

October 26, 2025

Advertisement

Commentary

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Commentary

How to Design (and How Not to Design) a Non-Inferiority Trial

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Real-World Data from Data Aggregators: Opportunities and Challenges

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

Mapping the Evidence: A Review of the Renal Denervation Clinical Trial Landscape

The Conformal LAAC Device: Status Update and Current IDE Clinical Trial

TCT 649: Five-Year Clinical Outcomes of the Randomized Controlled Trial of Angiography Versus Pressure Ratio-Guided Enhancement Techniques - Fractional Flow Reserve (TARGET-FFR)

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

TCT 982: Clinical Characteristics and Outcomes of Transcatheter Tricuspid Valve Replacement (TTVR) Patients Stratified by TRISCEND II Trial Eligibility

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content